CA
OCRX

Commerzbank Aktiengesellschaft’s Ocera Therapeutics, Inc. OCRX Stock Holding History

Commerzbank Aktiengesellschaft’s Portfolio OCRX Stock Details OCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-24,276
Closed -$256K – 1260
2014
Q1 		$256K Buy
+24,276
New +$347K ﹤0.01% 1122

Other funds holding OCRX

VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Commerzbank Aktiengesellschaft's OCRX Position: Q2 2014 in Review

Commerzbank Aktiengesellschaft sold out of Ocera Therapeutics, Inc. (OCRX) in Q2 2014, closing a stake of 24,276 shares — an estimated $256K sold.

Commerzbank Aktiengesellschaft first reported a position in OCRX in Q1 2014 and held it in 1 quarter. The position peaked at $256K in Q1 2014. 33 funds tracked by Wall St. Rank hold OCRX as of Q2 2014.

  • Commerzbank Aktiengesellschaft reported no remaining Ocera Therapeutics, Inc. position as of Q2 2014 after selling out during the quarter.
  • Commerzbank Aktiengesellschaft sold 24,276 Ocera Therapeutics, Inc. shares in Q2 2014, an estimated $256K.
  • Commerzbank Aktiengesellschaft first reported a position in Ocera Therapeutics, Inc. in Q1 2014 and held it in 1 quarter.
  • Commerzbank Aktiengesellschaft's Ocera Therapeutics, Inc. position peaked at $256K in Q1 2014.
  • 33 funds tracked by Wall St. Rank held Ocera Therapeutics, Inc. as of Q2 2014.

Based on Commerzbank Aktiengesellschaft's 13F filing for Q2 2014, filed 12 Aug 2014.